REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Goldman Slightly Less Negative On UK Grocers

Wed, 26th Oct 2016 08:29

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
GOLDMAN RAISES MORRISON SUPERMARKETS PRICE TARGET TO 180 (175) PENCE - 'SELL'
----------
GOLDMAN RAISES TESCO PRICE TARGET TO 145 (142) PENCE - 'SELL'
----------
GOLDMAN RAISES SAINSBURY TO 'SELL' (CONVICTION SELL LIST) - TARGET 195 (178) PENCE
----------
HSBC RAISES DIAGEO TO 'BUY' (HOLD) - PRICE TARGET 2600 (2350) PENCE
----------
JPMORGAN RAISES DIAGEO PRICE TARGET TO 2500 (2400) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ST JAMES'S PLACE TARGET TO 1096 (1015) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES ST JAMES'S PLACE PRICE TARGET TO 1095 (1060) PENCE - 'BUY'
----------
JPMORGAN RAISES EXPERIAN PRICE TARGET TO 1848 (1767) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES ANGLO AMERICAN PRICE TARGET TO 1150 (930) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES ANGLO AMERICAN PRICE TARGET TO 965 (940) PENCE - 'HOLD'
----------
MACQUARIE RAISES ANGLO AMERICAN PRICE TARGET TO 880 (815) PENCE - 'NEUTRAL'
----------
S&P GLOBAL RAISES ANGLO AMERICAN PRICE TARGET TO 970 (600) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES HSBC PRICE TARGET TO 585 (525) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS WHITBREAD PRICE TARGET TO 4550 (4665) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS WHITBREAD PRICE TARGET TO 4030 (4360) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS WHITBREAD PRICE TARGET TO 4100 (4220) PENCE - 'HOLD'
----------
UBS CUTS WHITBREAD PRICE TARGET TO 3900 (4050) PENCE - 'NEUTRAL'
----------
UBS RAISES INTERTEK PRICE TARGET TO 4100 (4000) PENCE - 'BUY'
----------
GOLDMAN RAISES WPP PRICE TARGET TO 2070 (1989) PENCE - 'BUY'
----------
GOLDMAN RAISES IMPERIAL BRANDS PRICE TARGET TO 4340 (4250) PENCE - 'BUY
----------
SocGen Cuts Informa Price Target To 780p From 845p, Reiterates Buy
----------
FTSE 250
----------
JPMORGAN RAISES SAGA PRICE TARGET TO 215 (190) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE CUTS INMARSAT PRICE TARGET TO 940 (1060) PENCE - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES BTG PRICE TARGET TO 865 (840) PENCE - 'BUY'
----------
GOLDMAN RAISES FIRSTGROUP PRICE TARGET TO 168 (146) P - 'CONVICTION BUY LIST'
----------
UBS RAISES BODYCOTE PRICE TARGET TO 705 (690) PENCE - 'BUY'
----------
HSBC CUTS LANCASHIRE HOLDINGS TO 'HOLD' ('BUY') - PRICE TARGET 730 PENCE
----------
HSBC RAISES NATIONAL EXPRESS PRICE TARGET TO 400 (385) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
PANMURE CUTS JOHNSTON PRESS PRICE TARGET TO 60 (200) PENCE - 'BUY'
----------
Investec Cuts Hostelworld To Hold From Buy, Target 225p From 210p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
15 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 14:59

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 15:07

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 16:11

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 15:21

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more
8 Jul 2015 15:20

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 14:51

Investec affirms 'buy' rating for BTG, confident about varicose vein treatment

Investec reiterated a 'buy' rating and price target of 647p for pharmaceuticals firm BTG after reappraising its key product Varithena. The bank said investors overreacted to concerns over BTG's earning profile, in particular the varicose vein treatment Varithena. "After interviewing physicians and

Read more
11 Jun 2015 10:26

WINNERS & LOSERS: RBS Rises, Royal Mail Sinks On UK Government Moves

Read more
11 Jun 2015 08:35

BROKER RATINGS SUMMARY: Liberum Raises Majestic Wine To Buy From Hold

Read more
11 Jun 2015 06:39

BTG Says First Patient Treated With TheraSphere In Singapore

Read more
27 May 2015 08:34

BROKER RATINGS SUMMARY: Brewin Dolphin Cut To Hold By Peel Hunt, Numis

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.